APS Pharmacy (Drug Depot, LLC)
Past issue, resolved — closeout on file (Oct 2023).
About this pharmacy
Legal entity: Drug Depot, LLC dbai APS Pharmacy
Facility type: 503A compounding pharmacyi.
The four standards
This standard has not yet been checked for this pharmacy.
In 2023, FDA inspectors found that drug products produced at this facility did not qualify for 503Ai compounding exemptions and that bulk drug substances were sourced from establishments not registered with FDA. APS Pharmacy corrected it, and FDA formally confirmed the correction in 2023.
(Method: checked against FDA’s public warning-letter and closeout-letter databases.)
Source: FDA warning letter — March 2023
This standard has not yet been checked for this pharmacy.
This standard has not yet been checked for this pharmacy.
Notes
This entity’s warning and closeout letters list Belmar Pharma Solutions leadership as CC’d contacts, suggesting a possible corporate/quality-oversight relationship. This relationship is not independently confirmed, so APS Pharmacy’s record is reported on its own rather than attributed to Belmar.
Frequently asked questions
Is APS Pharmacy (Drug Depot, LLC) accredited?
Accreditation has not yet been evaluated for APS Pharmacy (Drug Depot, LLC). This standard has not yet been checked for this pharmacy, so we cannot confirm or deny accreditation status at this time.
Has APS Pharmacy (Drug Depot, LLC) had any FDA regulatory actions?
Yes, but it was resolved. In 2023, FDA inspectors found that drug products produced at this facility did not qualify for 503A compounding exemptions and that bulk drug substances were sourced from establishments not registered with FDA. APS Pharmacy corrected it, and FDA formally confirmed the correction in 2023. Checked against FDA’s public warning-letter and closeout-letter databases.